Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Mustafa Özgüroğlu | Researchclopedia

Back to researchers

Mustafa Özgüroğlu

Istanbul University-Cerrahpaşa ORCID

546

Works

41,665

Citations

61

h-index

179

i10-index

Research Topics

Lung Cancer Research Studies Neuroendocrine Tumor Research Advances Peptidase Inhibition and Analysis

Affiliations

Université Paris-Sud2017–2017

Hebron University2020–2020

Üsküdar University2007–2007

Cliniques Universitaires Saint-Luc2011–2011

The University of Texas MD Anderson Cancer Center2013–2013

Top Works

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Scott Antonia,Augusto Villegas,et al.

20174,435 citations

Cancer Immunotherapy and Biomarkers

Prostate Cancer Treatment and Research

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

Johann S. de Bono,Stéphane Oudard,et al.

20103,267 citations

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

Scott Antonia,Augusto Villegas,et al.

20182,753 citations

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer

Karim Fizazi,NamPhuong Tran,et al.

20172,166 citations

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Luis Paz‐Ares,Mikhail Dvorkin,et al.

20192,111 citations

Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC

Roy S. Herbst,Giuseppe Giaccone,et al.

20201,644 citations

Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer

Kim N.,Neeraj Agarwal,et al.

20191,463 citations

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

Kohei Shitara,Mustafa Özgüroğlu,et al.

20181,309 citations

Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial

Karim Fizazi,NamPhuong Tran,et al.

2019796 citations